Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness.
Lau E, Kwong G, Fowler TW, Sun BC, Donohoue PD, Davis RT, Bryan M, McCawley S, Clarke SC, Williams C, Banh L, Irby M, Edwards L, Storlie M, Kohrs B, Lilley GWJ, Smith SC, Gradia S, Fuller CK, Skoble J, Garner E, van Overbeek M, Kanner SB.
Lau E, et al. Among authors: clarke sc.
Cytotherapy. 2023 Jul;25(7):750-762. doi: 10.1016/j.jcyt.2023.03.011. Epub 2023 Apr 21.
Cytotherapy. 2023.
PMID: 37086241
Free article.